Psychiatry and Neurology, Neurology · Chicago, IL
NPI
1285620617
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1725 W Harrison St, 1106
Chicago, IL, 60612
Phone (312) 942-4500
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
358 services
Medicare patients, 2024
253
Average age 61
Drug cost, 2024
$1.2M
2,265 prescriptions
Company payments, 2025
$18K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael C Smith was code 99214 (office e&m - established), 93 times for 74 patients. In total Michael C Smith billed 358 services in 18 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 93 | 74 | $83.10 | $7,728 |
| 95720 Neurologic | Facility | 65 | 43 | $168.75 | $11K |
| 99214 Office E&M - Established | Facility | 45 | 41 | $60.38 | $2,717 |
| 99443 Telephone Services | Office | 22 | 18 | $78.49 | $1,727 |
| 95812 Neurologic | Facility | 19 | 18 | $43.03 | $817 |
| 99204 Office E&M - New | Office | 17 | 17 | $116.55 | $1,981 |
| 95718 Neurologic | Facility | 16 | 16 | $110.29 | $1,765 |
| 95816 Neurologic | Facility | 16 | 16 | $45.37 | $726 |
| 99204 Office E&M - New | Facility | 12 | 12 | $101.88 | $1,223 |
By year: 2022 $38K for 400 services; 2023 $35K for 368 services; 2024 $34K for 358 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael C Smith prescribed most often to Medicare patients was Levetiracetam, with 249 prescriptions and refills. In total Michael C Smith wrote 2,265 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 249 | 541 | 70 | $13K |
| Lamotrigine Generic | 229 | 398 | 42 | $2,986 |
| Xcopri Cenobamate | 191 | 195 | 20 | $267K |
| Lacosamide Generic | 166 | 253 | 30 | $28K |
| Clobazam Generic | 99 | 128 | 15 | $13K |
| Lamotrigine Er Lamotrigine | 92 | 120 | Under 11 | $19K |
| Divalproex Sodium Er Divalproex Sodium | 74 | 122 | 16 | $9,160 |
| Gabapentin Generic | 64 | 98 | 13 | $1,653 |
| Topiramate Generic | 61 | 106 | Under 11 | $1,642 |
| Zonisamide Generic | 60 | 106 | 15 | $2,479 |
| Divalproex Sodium Generic | 55 | 75 | Under 11 | $4,981 |
| Carbamazepine Er Carbamazepine | 47 | 69 | Under 11 | $9,339 |
| Lorazepam Generic | 43 | 47 | 13 | $96.25 |
| Oxcarbazepine Generic | 42 | 88 | Under 11 | $2,571 |
| Clonazepam Generic | 42 | 62 | 11 | $423 |
Brand drugs: 575 claims; generic drugs: 1,667 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael C Smith $18K ($18K in general payments such as food, travel and fees) from 3 companies. The largest payer was SK Life Science, Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 17 | $18K |
| Forte Bio-Pharma LLC | 1 | $37.83 |
| Biocodex, Inc. | 1 | $13.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.